Role of magnesium supplementation in the treatment of depression: A randomized clinical trial
Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C
PloS one · 83 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- University of Vermont
- Universidad u hospital
- This work was supported by the Henry and Carleen Tufo fund of the University of Vermont.
Según 2 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2017-06-27 · PLoS One · vol. 12 · número 6 · pág. e0180067
- Editorial
- Public Library of Science
- Citado
- 154 citas · más que el 99% de estudios similares · 7.7× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 37 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Magnesium in Health and Disease · Bipolar Disorder and Treatment · Aluminum toxicity and tolerance in plants and animals
- Palabras clave
- Medicine, Randomized controlled trial, Anxiety, Depression (economics), Regimen, Internal medicine, Patient Health Questionnaire, Pill, Adverse effect, Clinical trial, Physical therapy, Depressive symptoms, Psychiatry
- MeSH
- humans, magnesium chloride, antidepressive agents, treatment outcome, cross-over studies, depressive disorder, adult, aged, middle aged, female, male
5 autores
- Emily K. Tarleton🇺🇸 · autor de correspondenciaUniversity of Vermont
- Benjamin Littenberg🇺🇸University of Vermont
- Charles D. MacLean🇺🇸University of Vermont
- Amanda G. Kennedy🇺🇸University of Vermont
- Christopher Daley🇺🇸University of Vermont
Resumen
El texto original del estudio, en el idioma en que se publicó.
Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and depression, yet its role in symptom management is unclear. The objective of this trial was to test whether supplementation with over-the-counter magnesium chloride improves symptoms of depression. An open-label, blocked, randomized, cross-over trial was carried out in outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-to-moderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5-19. The intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day) compared to 6 weeks of control (no treatment). Assessments of depression symptoms were completed at bi-weekly phone calls. The primary outcome was the net difference in the change in depression symptoms from baseline to the end of each treatment period. Secondary outcomes included changes in anxiety symptoms as well as adherence to the supplement regimen, appearance of adverse effects, and intention to use magnesium supplements in the future. Between June 2015 and May 2016, 112 participants provided analyzable data. Consumption of magnesium chloride for 6 weeks resulted in a clinically significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P<0.001) and net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4; P<0.001). Average adherence was 83% by pill count. The supplements were well tolerated and 61% of participants reported they would use magnesium in the future. Similar effects were observed regardless of age, gender, baseline severity of depression, baseline magnesium level, or use of antidepressant treatments. Effects were observed within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.